Regado Biosciences jumps on positive coverage

Recently-public Regado Biosciences (RGDO) trades 8.7% higher premarket on a bevy of bullish calls.

Cowen initiates coverage at Outperform.

Canaccord starts the shares at Buy. Price target is $14.

BMO weighs in with an Outperform rating and a $12 price target.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs